AB Science Logo

AB Science

AB | PA

Overview

Corporate Details

ISIN(s):
FR0010557264 (+1 more)
LEI:
969500U43TVR8CCVBJ97
Country:
France
Address:
3 AVENUE GEORGE V, 75008 PARIS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

AB Science, founded in 2001, is a clinical-stage pharmaceutical company specializing in the research, development, and commercialization of protein kinase inhibitors (PKIs). The company focuses on developing targeted therapies for diseases with high unmet medical needs. Its pipeline is centered on two lead compounds, masitinib and AB8939, which are being investigated for use in oncology (e.g., Acute Myeloid Leukemia), neurodegenerative disorders (e.g., ALS, Alzheimer's, Multiple Sclerosis), and inflammatory diseases. AB Science also commercializes Masivet®, a tyrosine kinase inhibitor for use in veterinary medicine.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for AB Science. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-04 07:58
Share Issue/Capital Change
AB Science annonce le succès d’un placement privé d’environ 2,55 millions d’eur…
French 332.3 KB
2025-08-04 07:58
Share Issue/Capital Change
AB Science announces the successful completion of a 2.55 million euros private …
English 323.2 KB
2025-07-24 07:56
Regulatory News Service
AB Science has received approval from several European countries to initiate th…
English 297.9 KB
2025-07-24 07:56
Legal Proceedings Report
AB Science a obtenu l'autorisation de plusieurs pays européens pour initier l’é…
French 273.3 KB
2025-06-23 08:03
Regulatory News Service
AB Science - New peer-reviewed data provide strong evidence supporting masitini…
English 307.5 KB
2025-06-23 08:03
Regulatory News Service
AB Science - De nouvelles données évaluées par des pairs apportent des preuves …
French 290.6 KB
2025-06-12 07:59
Legal Proceedings Report
AB Science annonce la délivrance d’un brevet canadien protégeant la composition…
French 197.9 KB
2025-06-12 07:59
Regulatory News Service
AB Science announces issuance of a Canadian patent protecting the composition o…
English 221.7 KB
2025-06-09 08:00
Regulatory News Service
AB Science annonce l’approbation par l’EMA de la prolongation de la durée de co…
French 164.5 KB
2025-06-09 08:00
Report Publication Announcement
AB Science announces EMA approval of Masivet shelf-life extension to 4 years
English 194.6 KB
2025-05-23 07:52
Share Issue/Capital Change
AB Science announces the settlement delivery of its latest capital increase for…
English 199.0 KB
2025-05-23 07:52
Share Issue/Capital Change
AB Science :
French 229.0 KB
2025-05-20 07:49
Share Issue/Capital Change
AB Science annonce le succès d'un placement privé de 1,8 millions d'euros
French 282.8 KB
2025-05-20 07:49
Share Issue/Capital Change
AB Science announces the successful completion of a EUR 1.8 million private pla…
English 269.4 KB
2025-05-19 07:51
Registration Form
AB Science receives Chinese patent protecting masitinib in the treatment of Cov…
English 229.5 KB

Automate Your Workflow. Get a real-time feed of all AB Science filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for AB Science via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK
Alkaloid AD Logo
Manufacturing pharmaceuticals, cosmetics, and botanicals for consumer and healthcare markets.
North Macedonia ALK